ISSN: 2155-9899
Michael G. Hanna Jr
Vaccinogen, Inc.
Tanzania
Commentary
Active (Patient Specific) Immunotherapy of Colon Cancer: A Transition from Preclinical Studies to Successful Clinical Trials
Author(s): Michael G. Hanna Jr.Michael G. Hanna Jr.
DOI:
10.4172/2155-9899.1000269